Paid Clinical Trials in Parma, OH
As of July 2026, 14 paid clinical trials are recruiting in Parma, Ohio. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Parma offers studies at sites including University Hospitals Parma Medical Center for conditions such as Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Parma
Filter results
14 clinical trials
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Top Research Study Locations in Parma
Researchers run research studies in Parma, OH at 3 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University Hospitals Parma Medical Center | Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma | 12 |
| MetroHealth Parma Medical Center | Lumbar Spinal Stenosis | 1 |
| Parma - Seidman Cancer Center | Cervical Cancer | 1 |
Active & Upcoming Studies in Parma (2026)
Recruiting trials in Parma grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (12 active studies)
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
Common conditions studied in Parma
- Endometrial Clear Cell Adenocarcinoma (2 active studies)
- Endometrial Dedifferentiated Carcinoma (2 active studies)
- Endometrial Endometrioid Adenocarcinoma (2 active studies)
- Endometrial Mixed Cell Adenocarcinoma (2 active studies)
- Endometrial Undifferentiated Carcinoma (2 active studies)
- Recurrent Endometrial Carcinoma (2 active studies)
Leading research sponsors in Parma
- NRG Oncology
- National Cancer Institute (NCI)
- Canadian Cancer Trials Group
- Pfizer
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Parma?
There are approximately 14 recruiting clinical trials in Parma, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Parma pay participants?
Most recruiting trials in Parma compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Parma?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Parma?
The most common conditions under active study in Parma include Endometrial Clear Cell Adenocarcinoma (2), Endometrial Dedifferentiated Carcinoma (2), Endometrial Endometrioid Adenocarcinoma (2), Endometrial Mixed Cell Adenocarcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Parma?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Parma on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Parma?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Parma?
Recruiting research sites in Parma include University Hospitals Parma Medical Center, MetroHealth Parma Medical Center, Parma - Seidman Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Parma right now?
The largest active categories in Parma are Cancer & tumors (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.